This was an exploratory analysis of data from a @-year , randomized , double-blind study of the dipeptidyl peptidase-@ inhibitor linagliptin @mg once daily ( n = @ ) versus the sulphonylurea glimepiride @-@mg once daily ( n = @ ) in patients with type @ diabetes uncontrolled by metformin .